Physician

Sandeepkumar Jagdishbhai Gupta, M.D.

According to 2025 Medicare claims, Sandeepkumar Gupta, M.D. (NPI: 1528485729) practices rheumatology in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is EMPOWERED ARTHRITIS AND RHEUMATOLOGY CENTER PLLC (NPI: 1568180495; TIN: 88-2631287) and primary practice location at 27511-5433. Gupta is affiliated with the WellStar Clinical Partners Medicare ACO, LLC (ACO ID: A4803), participating under the MSSP model.

Gupta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 225 traditional Medicare patients, billed 48,067 HCPCS/CPT codes, and received $893,208 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,539 prescription claims across 233 beneficiaries totaling $1,283,600 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 10 records totaling $535. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $5,582 to $893,208. Similarly, Part D prescription costs have moved sharply higher in recent years, from $963 to $1,283,600. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	35	76	$5,582
2019	119	170	$13,128
2020	149	256	$19,618
2021	292	18,674	$331,934
2022	370	40,269	$553,669
2023	186	9,576	$135,797
2024	225	48,067	$893,208

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	30	$963
2016	21	53	$3,252
2017	31	113	$42,499
2018	58	279	$254,316
2019	89	325	$302,862
2020	133	924	$545,925
2021	317	1,268	$914,292
2022	298	1,663	$1,909,315
2023	203	723	$336,075
2024	233	1,539	$1,283,600

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	41	62	$126
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	106	106	$103
96413	Administration of chemotherapy into vein, 1 hour or less	26	109	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	143	356	$87
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	146	427	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	53	1,484	$442,952
Enbrel Sureclick	Etanercept	23	644	$163,333
Cosentyx Unoready Pen	Secukinumab	16	448	$135,145
Kevzara	Sarilumab	23	644	$98,445
Orencia Clickject	Abatacept	13	364	$72,558

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$535	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sandeepkumar Jagdishbhai Gupta, M.D.?

Tedicare shows public-source Medicare data for Sandeepkumar Jagdishbhai Gupta, M.D. (NPI 1528485729), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sandeepkumar Jagdishbhai Gupta, M.D. have ACO affiliation data?

Sandeepkumar Jagdishbhai Gupta, M.D. is shown with ACO affiliation data for WellStar Clinical Partners Medicare ACO, LLC (MSSP, ACO ID A4803).

What billing organization is linked to Sandeepkumar Jagdishbhai Gupta, M.D.?

Sandeepkumar Jagdishbhai Gupta, M.D. is linked to EMPOWERED ARTHRITIS AND RHEUMATOLOGY CENTER PLLC (billing NPI 1568180495) in the available physician profile data.

Does Sandeepkumar Jagdishbhai Gupta, M.D. have Open Payments data?

Sandeepkumar Jagdishbhai Gupta, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.